Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Real-world studies involving over a thousand patients show that the company's digital cognitive behavioral therapy for insomnia significantly improves sleep quality compared to medication alone. Combination of dCBT-I and medication yields even higher response and remission rates. Benefits also extend to anxiety and depression symptom reduction. "Both dCBT-I and combination therapy achieved remarkable reductions of PSQI score at six-month follow-up... changes in all secondary outcomes indicated statistically significant benefits from dCBT-I..." "Three therapeutic modes had varied superiority in distinct subgroups... dCBT-I and combination therapy showed greater advantage than medication treatment..." The company provided data access/support for these large-scale real-world studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Slan Health.